Different clinical presentations of a lupus anticoagulant in the same family.
A young man who had suffered several episodes of deep-vein thrombosis of the legs since the age of 20 had a myocardial infarction at the age of 33, at which time both a prolonged partial thromboplastin time (PTT), compatible with a lupus anticoagulant (LA), and decreased fibrinolytic capacity (FC) were found. His sister presented with deep-vein thrombosis of a leg and subsequent pulmonary embolism when she was 18 years old. She had a miscarriage three years later and developed a hemolytic-uremic syndrome at the age of 35. The PT and FC were normal. Laboratory investigations of the parents revealed positive antinuclear antibodies in the mother's serum but no anomaly in the father. This study suggests a familial tendency to develop autoimmune disorders associated with LA and thromboembolic complications related to decreased FC.
Jolidon
R M
RM
Département de Médecine interne, Hôpital de la Ville, La Chaux-de-Fonds, Switzerland.
Knecht
H
H
Humair
L
L
de Torrente
A
A
D000328:Adult; D000368:Aged; D001779:Blood Coagulation Factors / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D005342:Fibrinolysis / Q000235:genetics; D006801:Humans; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000235:genetics*; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000235:genetics; D010314:Partial Thromboplastin Time; D012307:Risk Factors; D013924:Thrombophlebitis / Q000097:blood / Q000235:genetics*
D001779:Blood Coagulation Factors; D016682:Lupus Coagulation Inhibitor